MTOR and acute myeloid leukemia: Further studies on the interplay between FASN, mTOR and autophagy in AML transformation, progression and therapy resistance are warranted to improve our understanding of cell fate decisions and could potentially open new avenues to tackle this disease with improved differentiation therapies.